Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|June 20, 2007
Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patientsAndrea Pellagatti, Martin Jädersten, Ann-Mari Forsblom, et al.
Ejhaem|July 18, 2022
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survivalTor Persson Skare, Elin Sjöberg, Mattias Berglund, et al.
Cancers|March 10, 2022
Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin LymphomasIoanna Xagoraris, Pedro Farrajota Neves da Silva, Georgia Kokaraki, et al.
British Journal of Haematology|June 25, 2016
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab eraYngvild Nuvin Blaker, Signe Spetalen, Marianne Brodtkorb, et al.
Virchows Archiv : an International Journal of Pathology|November 5, 2021
Clinical and biological impact of SAMHD1 expression in mantle cell lymphomaMagali Merrien, Agata M Wasik, Elin Ljung, et al.
British Journal of Haematology|February 4, 2020
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapyThomas Menter, Alexandar Tzankov, Emanuele Zucca, et al.
Oncotarget|May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutationsChenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2007
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications--a study from the Lunenburg Lymphoma Biomarker ConsortiumDaphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, et al.
Pageof 11